Survival in primary inoperable breast cancer patients

European Journal of Gynaecological Oncology

Volumn 25, Issue 3, 2004, Pages 367-372

  Dimitrakakis, C ^a,b   Keramopoulos, A ^a  

^a IASO   (Greece)

^b NONE   (Greece)

Author keywords

Advanced breast cancer; Inoperable breast cancer; Prognosis; Survival; Treatment

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; HORMONE RECEPTOR; METHOTREXATE;

ADULT; AGED; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL RESEARCH; FEMALE; HUMAN; INOPERABLE CANCER; MAJOR CLINICAL STUDY; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GREECE; HUMANS; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM METASTASIS; PALLIATIVE CARE; RETROSPECTIVE STUDIES;

EID: 2342646246     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Dorr A.F., Bader J., Friedman M.A.: "Locally advanced breast cancer current status and future directions". Int. J. Radiation Oncol. Biol. Phys., 1989, 16 (3), 775.
2. Beahrs O.H., Henson D.E., Hutter R.V.P., Kennedy B.J.: "Handbook for staging of cancer". In manual for staging on cancer, edition 4, Philadelphia, Lippincott, 1993, 161.
3. Haagensen C.D., Stout A.P.: "Carcinoma of the breast. II. Criteria of inoperability". Ann. Surg., 1943, 118, 859.
4. Hortobagyi G.N.: "Multidisciplinary management of advanced primary and metastatic breast cancer". Cancer, 1994 (suppl.), 74 (1), 416.
5. Pearlman N.W., Guerra O., Fracchia A.A.: "Primary inoperable cancer of the breast". Surg. Gynecol. Obstet., 1976, 143 (6), 909.
6. Honkoop A.H., Wagstaff J., Pinedo H.M.: "Management of Stage III breast cancer". Oncology, 1998, 55 (3), 218.
7. Valero V., Buzdar A.U., Hortobagyi G.N. "Locally advanced breast cancer". Oncologist, 1996, 1 (4), 278.
8. Falkson G., Gelman R.S., Leone L., Falkson C.I.: "Survival of premenopausal women with metastatic breast cancer. Long-term follow-up of Eastern Cooperative Group and Cancer and Leukemia Group B studies". Cancer, 1990, 66 (7), 1621.
9. Bradburn M.J., Altman D.G., Smith P., Fentiman I.S., Rubens R.D.: "Time trends in breast cancer survival: experience in a single center, 1975-89". Br. J. Cancer, 1998, 77 (11), 1944.
10. Chittoor S.R., Swain S.M.: "Locally advanced breast cancer: role of medical oncology". In: K.I. Bland and E.M. Copeland, III (eds.). The Breast: Comprehensive Management of Benign and Malignant diseases. Philadelphia, Saunders, 1998, 1260.
11. Hortobagyi G.N., Buzdar A.U., Strom E.A., Ames F.C., Singletary S.E.: "Primary chemotherapy for early and advanced breast cancer". Cancer Lett., 1995, 90 (1), 103.
12. Morrell L.E., Lee Y.J., Hurley J., Arias M., Mies C., Richman S.P. et al.: "A Phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinoma". Cancer, 1998, 82 (3), 503.
13. Hortobagyi G.N., Ames F.C., Buzdar A.U., Kau S.W., McNeese M.D., Paulus D. et al.: "Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy". Cancer, 1988, 62 (12), 2507.
14. Jacquillat C., Weil M., Baillet F., Borel C., Auclerc G., de Maublanc M.A. et al.: "Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer". Cancer, 1990, 66 (1), 119.
15. Abdel-Wahab M., Wolfson A., Raub W., Mies C., Brandon A., Morrell L. et al.: "The importance of postoperative radiation therapy in multimodality management of locally advanced breast cancer: a phase II trial of neoadjuvant MVAC, surgery, and radiation". Int. J. Radiat. Oncol. Biol. Phys., 1998, 40 (4), 875.
16. Blumenschein G.R., DiStefano A., Caderao J., Fristenberg B., Adams J., Schweichler L.H. et al.: "Multimodality therapy for locally advanced and limited Stage IV breast cancer: the impact of effective non-cross-resistance late-consolidation chemotherapy". Clin. Cancer Res., 1997, 3 (12 pt 2), 2633.
17. Glinski B., Pawlicki M., Reinfuss M., Skolyszewski J., Brandys A., Krzemieniecki K. et al.: "Multimodality treatment of noninflammatory Stage IIIb breast cancer". J. Surg. Oncol., 1997, 66 (3), 179.
18. Bartelink H., Rubens R.D., van der Schueren E., Sylvester R.: "Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European Organization for Research and Treatment of Cancer Randomized Phase III Trial". J. Clin. Oncol., 1997, 15 (1), 207.
19. Hortobagyi G.N.: "Comprehensive management of locally advanced breast cancer". Cancer, 1990, 66 (suppl. 6), 1387.
20. Armstrong D.K., Fetting J.H., Davidson N.E., Gordon G.B., Huelskamp A.M., Abeloff M.D.: "Sixteen week dose intense chemotherapy for inoperable, locally advanced breast cancer". Breast Cancer Res. Treat., 1993, 28 (3), 277.
21. Luboinski G., Nagadowska M., Pienkowski T.: "Preoperative chemotherapy in primarily inoperable cancer of the breast". Eur. J. Surg. Oncol., 1991, 17 (6), 603.
22. Hunt K.K., Ames F.C., Singletary S.E., Buzdar A.U., Hortobagyi G.N.: "Locally advanced noninflammatory breast cancer". Surg. Clin. North Am., 1996, 76 (2), 393.
23. Billgren A.M., Rutqvist L.E., Tani E., Wilking N., Fornander T., Skoog L.: "Proliferating fraction during neoadjuvant chemotherapy of primary breast cancer in relation to objective local response and relapse-free survival". Acta Oncol., 1999; 38 (5), 597.
24. Hortobagyi G.N., Blumenschein G.R., Spanos W., Montague E.D., Buzdar A.U., Yap H.Y. et al.: "Multimodal treatment of locoregionally advanced breast cancer". Cancer, 1983, 51 (5), 763.
25. Dunphy F.R., Spitzer G., Fornoff J.E., Yau J.C., Huan S.D., Dicke K.A et al.: "Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support". Cancer, 1994, 73 (8), 2157.
26. Hunt K.K., Kroll S.S., Pollock R.E.: "Surgical procedures for advanced local and regional malignancies of the breast". In: K.I. Bland and E.M. Copeland, III (eds.). The Breast: Comprehensive Management of Benign and Malignant Diseases. Philadelphia, Saunders, 1998, 1234.
27. Hortobagyi G.N., Spanos W., Montague E.D., Buzdar A.U., Yap H.Y., Blumenschein G.R.: "Treatment of locoregionally advanced breast cancer with surgery, radiotherapy, and combination chemoimmunotherapy". Int. J. Radiat. Oncol. Biol. Phys., 1983, 9 (5), 643.
28. Kantarjian H.M., Hortobagyi G.N., Smith T.L., Blumenschein G.R., Montague E., Buzdar A.U. et al.: "The management of locally advanced breast cancer: a combined modality approach". Eur. J. Cancer Clin. Oncol., 1984, 20 (11), 1353.
29. Smith I.E.: "Patients benefit from new treatment options and schedules for breast cancer". Semin. Oncol., 1997, 24 (4) (suppl. 10), 10.
30. Paterson A.H., Zuck V.P., Szafran O., Lees A.W., Hanson J.: "Influence and significance of certain prognostic factors on survival in breast cancer". Eur. J. Cancer Clin. Oncol., 1982, 18 (10), 937.
31. Reichman B.S., Osborne M.P.: "Detection of occult micrometastatic disease". In: K.I. Bland and E.M. Copeland, III (eds.). The Breast: Comprehensive Management of Benign and Malignant Diseases. Philadelphia, Saunders, 1998, 1299.
32. Vincent M.D., Powles T.J., Skeet R., Ashley S., Coombes R.C., Gibb J. et al.: "An analysis of possible prognostic features of long term and short term survivors of metastatic breast cancer". Eur. J. Cancer Clin. Oncol., 1986, 22 (9), 1059.
33. Nomura Y., Tashiro H., Osaki A.: "Long term survival and the prognostic factors of advanced breast cancer patients treated with adreno-oophorectomy". Breast Cancer Res. Treat., 1995, 33 (1), 47.